Senzime Expands its US Commercial Operations

2 years ago

UPPSALA, SE / ACCESSWIRE / January 17, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions,…

Smoking Claims More Than 6,500 Lives, Costs Minnesota Over $9 Billion Annually 

2 years ago

New report commissioned by Blue Cross and Blue Shield of Minnesota exposes the ramifications of smoking on health and the…

CPSI Announces Divestment of American HealthTech to PointClickCare

2 years ago

MOBILE, Ala.--(BUSINESS WIRE)--CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that the Company has divested its subsidiary, American HealthTech,…

Fathom Announces Partnership with Google Cloud, Adding its Autonomous Medical Coding Solution to Google Cloud Marketplace

2 years ago

This collaboration will boost access and integration with best-in-class autonomous medical coding for healthcare providers.SAN FRANCISCO--(BUSINESS WIRE)--#AutonomousMedicalCoding--Fathom, the leader in…

FDA Clearance Granted for First AI-Powered Medical Device to Detect All Three Common Skin Cancers (Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma)

2 years ago

DermaSensor Now Available to Improve Skin Cancer Detection in Primary CareMIAMI--(BUSINESS WIRE)--DermaSensor Inc. announces FDA clearance for its real-time, non-invasive…

The First Breathing For Diabetes App to Improve the Quality of Life for 537 Million People

2 years ago

New York, New York--(Newsfile Corp. - January 17, 2024) - The Breathing App has launched the first app that allows…

Luxury Addiction Rehab Expands Services Amid Rebranding

2 years ago

Private addiction and dual diagnosis treatment center Annandale Behavioral Health develops a comprehensive continuum of care for drug and alcohol…

AMC Health Announces Dr. Zebadiah Kimmel, MD, MBA, as Chief Product Officer

2 years ago

Dr. Kimmel brings more than 15 years of leadership to AMC HealthNEW YORK, NY / ACCESSWIRE / January 17, 2024…

CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

2 years ago

HOUSTON, TX / ACCESSWIRE / January 17, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company…

NurExone and Inteligex Kick Off Chronic Spinal Cord Injury Research for Multi-Billion Dollar Healthcare Market

2 years ago

TORONTO and HAIFA, Israel, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company”…